The CACNA1A Gene Familial Hemiplegic Migraine Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CACNA1A gene, which are associated with Familial Hemiplegic Migraine Type 1 (FHM1). FHM1 is a rare subtype of migraine with aura, characterized by temporary paralysis on one side of the body, visual disturbances, and in some cases, speech difficulties and confusion. The condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene can lead to the disorder.
The test is crucial for individuals with a family history of FHM1 or those exhibiting symptoms, as a positive result can confirm the diagnosis, enabling tailored treatment plans and lifestyle adjustments to manage symptoms effectively. Additionally, it provides essential information for family planning decisions.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA sample, usually obtained through a blood draw or a cheek swab, to detect mutations in the CACNA1A gene. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify the genetic variations associated with the condition.
This genetic test represents a significant step forward in personalized medicine, offering hope and clarity to families affected by Familial Hemiplegic Migraine Type 1.
The ATP1A2 gene plays a crucial role in the proper functioning of brain cells. Mutations in this gene are associated with familial hemiplegic migraine type 2 (FHM2), a rare form of migraine characterized by severe headache accompanied by temporary paralysis on one side of the body (hemiplegia), sensory disturbances, and, in some cases, coma or seizure-like episodes. These symptoms are much more severe than those of a typical migraine.
To diagnose this condition accurately, genetic testing is available at DNA Labs UAE, which specifically looks for mutations in the ATP1A2 gene. This test is vital for individuals with a family history of FHM2 or those who exhibit symptoms suggestive of this condition. By identifying mutations in the ATP1A2 gene, healthcare providers can confirm a diagnosis of familial hemiplegic migraine type 2, which can significantly aid in the management and treatment of the condition.
The cost of the ATP1A2 gene familial hemiplegic migraine type 2 genetic test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted by healthcare professionals who specialize in genetic testing, ensuring accurate and reliable results. Opting for this test at DNA Labs UAE not only provides individuals with a definitive diagnosis but also helps in understanding the genetic basis of their condition, which is crucial for making informed decisions about treatment and management.
The SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the SCN1A gene, which have been associated with Familial Hemiplegic Migraine Type 3 (FHM3). Familial Hemiplegic Migraine is a rare subtype of migraine with aura, characterized by temporary paralysis on one side of the body, visual disturbances, and sometimes speech difficulties before the onset of headache. The SCN1A gene plays a crucial role in the functioning of nerve cells in the brain, and mutations in this gene can disrupt ion channels, leading to the symptoms of FHM3.
This genetic test is crucial for individuals with a family history of FHM3, as it can provide definitive confirmation of the mutation presence, aiding in the accurate diagnosis and management of the condition. The test involves a simple blood draw or cheek swab, with the sample then analyzed for specific genetic mutations in the SCN1A gene.
The cost of the SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its importance in the precise diagnosis and potential treatment strategies for individuals with or at risk of FHM3, the investment can be invaluable for affected families seeking clarity on their genetic status and how it may impact their health management plans.
The DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. Priced at 4400 AED, this test is designed to detect mutations in the DST gene, which are responsible for the autosomal recessive form of Epidermolysis Bullosa Simplex (EBS) type 2. EBS is a group of genetic conditions that result in fragile skin that blisters easily from minor injuries or friction. The DST gene plays a critical role in the formation and function of the skin and other tissues, and mutations in this gene can lead to the symptoms associated with EBS.
This test is particularly important for individuals who have a family history of EBS or have symptoms suggestive of the condition. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of genetic abnormalities in the DST gene. The results from this test can provide crucial information for diagnosis, allowing for appropriate management and care strategies to be implemented. Additionally, it can offer valuable insights for family planning decisions for those with a history of the condition. DNA Labs UAE provides this test with the aim of offering precise and reliable genetic testing services to help manage and understand hereditary conditions like EBS.
The "GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GRIN2A gene, which have been linked to various forms of epilepsy accompanied by neurodevelopmental defects. This test is particularly crucial for individuals who exhibit symptoms of epilepsy along with cognitive, behavioral, or motor development issues, as it can provide a definitive genetic diagnosis. The GRIN2A gene plays a significant role in the functioning of NMDA receptors, which are vital for synaptic transmission and plasticity in the brain, influencing learning and memory. Mutations in this gene can disrupt these processes, leading to the aforementioned conditions.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the GRIN2A gene. The results can offer valuable insights into the specific type of epilepsy and neurodevelopmental disorder the individual might have, guiding treatment decisions and management strategies. It can also provide information on the risk of passing the condition to future offspring, which is crucial for family planning.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the GRIN2A gene. While the price might seem high, the potential benefits of obtaining a precise diagnosis and the consequent tailored treatment plan can be invaluable for affected individuals and their families. DNA Labs UAE is equipped with state-of-the-art facilities and employs experts in genetic testing, ensuring high-quality services and reliable results.
The GABRG2 gene is associated with a form of epilepsy known as childhood absence epilepsy type 2, a condition characterized by frequent, brief loss of consciousness and staring spells. This condition often starts in childhood and can significantly impact an individual's quality of life. The GABRG2 gene plays a crucial role in the functioning of GABA receptors, which are involved in inhibiting nerve transmission in the brain, and mutations in this gene can disrupt this process, leading to seizures.
DNA Labs UAE offers a specialized genetic test to identify mutations in the GABRG2 gene, which can be instrumental in diagnosing childhood absence epilepsy type 2. This test is particularly valuable for families with a history of this condition, providing them with crucial information that can guide treatment and management strategies. The test is priced at 4400 AED and involves a simple procedure, typically requiring only a blood sample or cheek swab from the patient.
By identifying specific genetic mutations associated with epilepsy, this test enables healthcare providers to offer a more personalized approach to treatment, potentially improving outcomes for affected individuals. It also offers families the opportunity to understand their risk of passing the condition onto future generations, aiding in informed family planning decisions.
The GABRA1 gene plays a crucial role in the normal functioning of the brain. Mutations in this gene are associated with several forms of epilepsy, including Childhood Absence Epilepsy Type 4 (CAE4), a condition characterized by frequent absence seizures that begin in childhood. These seizures involve brief episodes of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To identify susceptibility to CAE4, genetic testing for mutations in the GABRA1 gene is available. Conducted at DNA Labs UAE, this specialized test offers a comprehensive analysis of the GABRA1 gene to detect mutations that may predispose an individual to this form of epilepsy. The test is a critical tool for early diagnosis, allowing for timely intervention and management of the condition.
The cost of the GABRA1 gene epilepsy susceptibility test is 4400 AED. This investment covers the genetic analysis and the professional interpretation of results, providing valuable insights into the individual's genetic predisposition to CAE4. Early detection through this test can lead to better management strategies, potentially improving the quality of life for those affected by this condition.
The GABRB3 gene plays a crucial role in the development and function of the brain, particularly in the regulation of neurotransmission. Mutations in this gene have been linked to various neurological conditions, including Epilepsy Childhood Absence Type 5 (ECAT5). This specific type of epilepsy is characterized by frequent absence seizures that begin in childhood, significantly affecting attention and learning.
To diagnose and manage ECAT5 effectively, genetic testing for mutations in the GABRB3 gene is essential. DNA Labs UAE offers a comprehensive genetic test designed to identify mutations in the GABRB3 gene that are associated with Epilepsy Childhood Absence Type 5. This test is a valuable tool for clinicians in confirming the diagnosis, which can then guide treatment decisions and genetic counseling.
The cost of the GABRB3 gene epilepsy genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the GABRB3 gene. The results of this test can provide crucial information for the effective management and treatment of individuals with ECAT5, offering them a better quality of life.
The CACNA1H gene plays a crucial role in the proper functioning of the body's cellular electrical signaling, which is essential for the normal operation of various physiological processes, including those in the brain. Mutations in the CACNA1H gene have been linked to epilepsy childhood absence type 6 (ECAT6), a specific form of epilepsy characterized by frequent, brief absence seizures that begin in childhood. These seizures involve short periods of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To aid in the diagnosis and management of ECAT6, genetic testing for mutations in the CACNA1H gene is available. This test can confirm a diagnosis, help predict the course of the disease, and inform treatment decisions. Conducted at specialized facilities such as DNA Labs UAE, this genetic test involves analyzing the patient's DNA to identify mutations in the CACNA1H gene that are associated with the condition.
The cost of the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test at DNA Labs UAE is 4400 AED. This price may reflect the comprehensive nature of the testing process, which includes the collection of a DNA sample, usually through a blood draw or cheek swab, followed by sophisticated genetic analysis in the laboratory. The result from this test not only helps in confirming the diagnosis but also plays a critical role in the personalized treatment planning, offering a targeted approach based on the individual's genetic makeup.
In summary, the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test is a valuable diagnostic tool offered at DNA Labs UAE, with the potential to significantly impact the management and treatment of affected individuals by providing precise genetic insights into their condition.
The DEPDC5 gene plays a significant role in the development of familial focal epilepsy with variable foci, a complex form of epilepsy characterized by seizures originating in different parts of the brain. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene is sufficient to increase the risk of developing epilepsy.
DNA Labs UAE offers a specialized genetic test to identify mutations in the DEPDC5 gene, providing essential information for families affected by this condition. The test is crucial for accurate diagnosis, understanding the risk of transmission to offspring, and guiding treatment decisions. The cost of the test is 4400 AED, making it a valuable investment for families seeking insights into their genetic predisposition to familial focal epilepsy with variable foci. This test is a step forward in personalized medicine, allowing for tailored treatment plans based on genetic makeup.
